Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$55.54 - $72.65 $2.03 Million - $2.65 Million
-36,530 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$24.28 - $56.64 $886,948 - $2.07 Million
36,530 New
36,530 $2.02 Million
Q4 2021

Feb 14, 2022

SELL
$22.54 - $30.44 $540,960 - $730,560
-24,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$24.23 - $28.59 $581,520 - $686,160
24,000 New
24,000 $616,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.59B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.